Analyst firms · Piper Sandler · OGN

Piper Sandler OGN price target and rating history

Organon & Co. (OGN) · Health Care

Piper Sandler rates Organon & Co. (OGN) Neutral with a $14 price target, as of its latest action on Apr 28, 2026. It has published 4 rating actions on OGN since October 2021, including 2 upgrades and 1 downgrade.

Current rating
Neutral
Price target
$14
Median target, all firms
Too few
Actions on OGN
4

Piper Sandler price target on OGN

$35$20$520222023202420252026
Piper Sandler price target on OGN, each point a stated target, October 2021 to April 2026.

Every Piper Sandler rating on OGN

How other firms rate OGN

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Piper SandlerNeutral$14Apr 28, 2026
BarclaysUnderweight$7.50Dec 9, 2025

Questions about Piper Sandler and OGN

What is Piper Sandler's price target for OGN?
Piper Sandler's latest stated price target for Organon & Co. (OGN) is $14, from its action on Apr 28, 2026.
What is Piper Sandler's rating on OGN?
Piper Sandler rates OGN Neutral, a neutral rating, as of Apr 28, 2026.
When did Piper Sandler last change its view on OGN?
On Apr 28, 2026, Piper Sandler upgrades to Neutral from Underweight, price target $14.

More OGN rating histories

All Piper Sandler ratingsOGN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.